No profile data available.
Myomo, Inc. (MYO) is a healthcare company in the bone and joint treatment equipment industry, based in Burlington, United States, with about 184 full-time employees.
It reported revenue of $32.55 million for fiscal year 2024, up 69.2% from fiscal year 2023, and net income of -$6.18 million. In Q3 2025 (the quarter ended September 30, 2025) revenue was $10.09 million, up 9.6% from a year before. United States was its largest region in fiscal year 2025, with 83% of revenue. Its market capitalization was $39.20 million as of December 4, 2025.
Figures from company filings and market data; latest fiscal year ended December 31, 2024; market data as of December 4, 2025.
, a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, Germany, and internationally.
Myomo reported $32.55 million in revenue for fiscal year 2024, up 69.2% from $19.24 million in fiscal year 2023. In Q3 2025 revenue was $10.09 million.
United States: 83% of revenue by region in fiscal year 2025, followed by Germany (16%).
$39.20 million as of December 4, 2025.
Listed companies of a similar size in the same industry (bone and joint treatment equipment) include Treace Medical Concepts, Inc. (TMCI), Monogram Technologies Inc. (MGRM), Xtant Medical Holdings, Inc. (XTNT), Lifeward Ltd. (LFWD).